Reproduction permitted for personal use only. For reprints and reprint permission, contact email@example.com.
- Perscitus Biosciences, a Madison biotechnology company, has received a $250,000 loan from the Wisconsin Department of Commerce
Perscitus Biosciences was founded in 2006 to develop and commercialize two technologies based on reactive oxygen biochemistry. James Thomas, CEO and chairman of Perscitus Biosciences, said the Commerce loan will be used to purchase equipment and hire researchers to further develop its technologies and attract additional investment.
The first technology is a compound that selectively protects normal cells from the toxic effects of chemotherapy and radiation therapy. The second technology is a method for determining the function of unknown proteins by identifying protein binding partners in intact cells using reactive oxygen.
Thomas said the company has rapidly achieved its early proof-of-concept milestones.Related stories
Madison stem cell company gets $1M from state
Doyle announces technology tax credits for Berbee
State to fund two minority-owned tech businesses